Infection: friend or foe to the development of asthma?

Carlsen K-;H., Sterk P.J.

Source: Eur Respir J 2001; 18: 744-747

Journal Issue: November

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Carlsen K-;H., Sterk P.J.. Infection: friend or foe to the development of asthma?. Eur Respir J 2001; 18: 744-747

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Inflammation: friend or foe of muscle remodelling in COPD? Source: Eur Respir J 2007; 30: 605-607 Year: 2007
Bacterial colonisation in COPD: friend or foe? Source: Annual Congress 2010 - PG11 Postgraduate Course: Infection: a player in the natural history of COPD Year: 2010
Cellular senescence: friend or foe to respiratory viral infections? Source: Eur Respir J, 56 (6) 2002708; 10.1183/13993003.02708-2020 Year: 2020
Inhaled corticosteroids in COPD: friend or foe? Source: Eur Respir J, 52 (6) 1801219; 10.1183/13993003.01219-2018 Year: 2018
Calcineurin inhibitors: friend and foe? Source: School Course 2012 - Lung Transplantation Year: 2012
Infection: friend or foe in the development of atopy and asthma? The epidemiological evidence Source: Eur Respir J 2001; 18: 872-881 Year: 2001
Adaptation to oxidative stress induced-lung injury: friend or foe of influenza infection? Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018
Tobacco smoke: old foe more important for asthma than commonly appreciated? Source: Eur Respir J 2004; 24 : 720-721 Year: 2004
Mechanical ventilation: a friend and a foe Source: International Congress 2015 – ME3 Mechanical ventilation: a friend and a foe Year: 2015
FeNO for the diagnosis of asthma: foe Source: Virtual Congress 2021 – Fractionated exhaled nitric oxide for the diagnosis of asthma: friend or foe? Year: 2021
Treating inflammation: should we bother? Source: International Congress 2017 – Cystic fibrosis in children and adults: treatment dilemmas Year: 2017
The "Coil Associated Opacity" in endoscopic emphysema treatment. Friend or foe? Source: International Congress 2018 – Endoscopic lung volume reduction Year: 2018
Fixed-dose combination and therapeutic drug monitoring in tuberculosis: friend or foe? Source: Eur Respir J 2016; 48: 1230-1233 Year: 2016
Oxygen, the lung and the diver: friends and foes? Source: Eur Respir Rev 2016; 25: 496-505 Year: 2016
COPD: Still a Cinderella? Source: Eur Respir J 2003; 22: Suppl. 45, 67s Year: 2003
Electronic cigarette: Friend or foe? Source: International Congress 2016 – Electronic cigarettes Year: 2016
A wheezing infant: a joy forever? Source: Annual Congress 2012 - Paediatric Grand Round - an interactive session Year: 2012
Paediatric asthma: where to go? Source: Eur Respir Rev 2012 21:173-174 Year: 2012